ORAL SMALL MOLECULE GLP-1 RECEPTOR AGONIST ALENIGLIPRON IN PEOPLE WITH OVERWEIGHT OR OBESITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL

Descargar Publicación
The gut-bone axis: impact of diet on gut microbiome and osteoporosis Obesity Pharmacotherapy: An Urgent Need for Progressing Science, Access, and Equity—JACC: Advances Expert Panel